parecoxib has been researched along with aprepitant in 1 studies
Studies (parecoxib) | Trials (parecoxib) | Recent Studies (post-2010) (parecoxib) | Studies (aprepitant) | Trials (aprepitant) | Recent Studies (post-2010) (aprepitant) |
---|---|---|---|---|---|
436 | 186 | 229 | 769 | 229 | 521 |
Protein | Taxonomy | parecoxib (IC50) | aprepitant (IC50) |
---|---|---|---|
Cytochrome P450 3A4 | Homo sapiens (human) | 0.046 | |
Substance-P receptor | Homo sapiens (human) | 0.0002 | |
Substance-P receptor | Meriones unguiculatus (Mongolian gerbil) | 0.0001 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chizh, BA; Göhring, M; Koppert, W; Quartey, GK; Schmelz, M; Tröster, A | 1 |
1 trial(s) available for parecoxib and aprepitant
Article | Year |
---|---|
Effects of oral pregabalin and aprepitant on pain and central sensitization in the electrical hyperalgesia model in human volunteers.
Topics: Administration, Oral; Adult; Analgesics; Aprepitant; Cross-Over Studies; Cyclooxygenase Inhibitors; Double-Blind Method; Drug Therapy, Combination; Electric Stimulation; Female; gamma-Aminobutyric Acid; Humans; Hyperalgesia; Isoxazoles; Male; Middle Aged; Morpholines; Pain Measurement; Pregabalin; Treatment Outcome | 2007 |